AU7516098A - Immunomodulating, bile-derivable compositions for the treatment of viral disorders - Google Patents
Immunomodulating, bile-derivable compositions for the treatment of viral disordersInfo
- Publication number
- AU7516098A AU7516098A AU75160/98A AU7516098A AU7516098A AU 7516098 A AU7516098 A AU 7516098A AU 75160/98 A AU75160/98 A AU 75160/98A AU 7516098 A AU7516098 A AU 7516098A AU 7516098 A AU7516098 A AU 7516098A
- Authority
- AU
- Australia
- Prior art keywords
- immunomodulating
- derivable
- bile
- compositions
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/37—Digestive system
- A61K35/413—Gall bladder; Bile
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Physiology (AREA)
- Virology (AREA)
- Developmental Biology & Embryology (AREA)
- Nutrition Science (AREA)
- Cell Biology (AREA)
- Gastroenterology & Hepatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA002206047A CA2206047A1 (en) | 1997-05-23 | 1997-05-23 | Immunomodulating compositions for the treatment of viral disorders |
CA2206047 | 1997-05-23 | ||
PCT/CA1998/000494 WO1998052585A1 (en) | 1997-05-23 | 1998-05-22 | Immunomodulating, bile-derivable compositions for the treatment of viral disorders |
Publications (1)
Publication Number | Publication Date |
---|---|
AU7516098A true AU7516098A (en) | 1998-12-11 |
Family
ID=4160728
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU75160/98A Abandoned AU7516098A (en) | 1997-05-23 | 1998-05-22 | Immunomodulating, bile-derivable compositions for the treatment of viral disorders |
Country Status (3)
Country | Link |
---|---|
AU (1) | AU7516098A (en) |
CA (1) | CA2206047A1 (en) |
WO (1) | WO1998052585A1 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001045727A2 (en) * | 1999-12-20 | 2001-06-28 | New Pharma Research Sweden Ab | Stabilized veterinary compositions comprising more than one antiviral agent |
WO2002038164A1 (en) | 2000-11-08 | 2002-05-16 | Lorus Therapeutics Inc. | Combination preparation of a biological response modifier and an anticancer agent and uses thereof |
ITRM20010688A1 (en) | 2001-11-21 | 2003-05-21 | Univ Roma | IMMUNOREGULATORY COMPOUNDS. |
CN115414370A (en) * | 2022-10-14 | 2022-12-02 | 华中农业大学 | Application of sodium taurocholate in preparing medicine for treating or preventing influenza virus infection |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE244570T1 (en) * | 1993-09-09 | 2003-07-15 | Lorus Therapeutics Inc | IMMUNOMODULATING COMPOSITIONS FROM BIL |
CN1108556A (en) * | 1994-03-28 | 1995-09-20 | 李秀彩 | Method for preparation of eyedrops |
CN1114566A (en) * | 1994-07-06 | 1996-01-10 | 云南滇东北制药总厂 | Spray for preventing AIDS and VD and preparation method thereof |
KR19980703088A (en) * | 1995-03-16 | 1998-09-05 | 라카일레 지, 필리페 | An inkjet recording paper comprising a new precipitated calcium carbonate pigment |
-
1997
- 1997-05-23 CA CA002206047A patent/CA2206047A1/en not_active Abandoned
-
1998
- 1998-05-22 AU AU75160/98A patent/AU7516098A/en not_active Abandoned
- 1998-05-22 WO PCT/CA1998/000494 patent/WO1998052585A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
CA2206047A1 (en) | 1998-11-23 |
WO1998052585A1 (en) | 1998-11-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2053597A (en) | Pharmaceutical compositions for the treatment of glaucoma | |
AU6513298A (en) | Therapeutic compositions | |
AU6405198A (en) | Plant for the treatment of products, which includes means for characterizing the products | |
AU1774097A (en) | Pharmaceutical compositions for the treatment of rhinitis | |
AU2759800A (en) | Processes and intermediates for the preparation of 1,3-oxazin-6-ones and uracils | |
HUP0004085A3 (en) | Novel 3,6-hemiketals from the class of 9a-azalides | |
AU2021601A (en) | Composition for the treatment of dandruff | |
IL139023A0 (en) | Process for the preparation of 2,3,5-trimethyl-p- benzoquinone | |
AU3814599A (en) | Use of erythropoietin for the treatment of haemochromatoses | |
AU3896899A (en) | Compositions for the treatment of tumors, and uses thereof | |
AU2002330042A1 (en) | Process for the preparation of 1,5-diarylpyrazoles | |
HUP0003452A3 (en) | Process for the preparation of 1-aryl-3-cyclopropyl-1,3-propanediones | |
AU7516098A (en) | Immunomodulating, bile-derivable compositions for the treatment of viral disorders | |
ZA982255B (en) | Process for the preparation of arylmalonates. | |
AU686084B3 (en) | Pharmaceutical compositions for the treatment of depressive disorders | |
AU5494298A (en) | Pharmaceutical compositions for the treatment of the eye | |
AU2829700A (en) | Processes for the preparation of alpha-aminoketones | |
AU6870500A (en) | Process for the preparation of 2,3-dihydroazepine derivatives | |
AU6870600A (en) | Process for the preparation of 2,3-dihydroazepine compounds | |
AU9198698A (en) | Process for the preparation of substituted 5,6-dihydro-2h-pyran-2-ones | |
AU5779998A (en) | Process for the preparation of cyanoarylmethylamine | |
AU5982199A (en) | Process for the preparation of 4,4'-dihalogen-o-hydroxydiphenyl compounds | |
AU6281199A (en) | Process for the preparation of cyclopropylacetylene | |
ZA986224B (en) | Immunomodulating compositions for the treatment of viral disorders | |
AU2537200A (en) | Atomizer |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |